- $1.35bn
- $5.45bn
- $352.58m
- 44
- 54
- 70
- 57
R2019 December 31st | R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 274 | 300 | 187 | 270 | 353 |
Cost of Revenue | |||||
Gross Profit | 96.8 | 77 | 184 | 267 | 348 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 471 | 456 | 122 | 135 | 430 |
Operating Profit | -198 | -156 | 65.2 | 136 | -77.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -155 | -116 | 73.4 | 145 | -52.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -156 | -119 | 73.4 | 145 | -54.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 324 | -42.4 | 73.1 | 135 | -55 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 292 | -65.9 | 73.1 | 135 | -55 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -16.4 | -12.5 | 1.29 | 1.28 | 0.781 |
Dividends per Share |